Fresenius Group 

Fresenius is a health care Group with products and services for dialysis, the hospital and the medical care of patients at home. In addition, Fresenius focuses on hospital management as well as on engineering and services for hospitals and other health care facilities. About 114,000 employees work with dedication in the service of health in around 100 countries of the globe.

  FRESENIUS GROUP IN FIGURES
  in million €

 2007

 2006

 2005

 2004

 2003
 
Earnings          
Sales 11,358 10,777 7,889 7,271 7,064
EBIT 1,609 1,444 969 845 781
Net income 410 330 222 168 115
Depreciation and amortization 421 399 320 315 325
Operating cash flow 1,296 1,052 780 851 776
Operating cash flow in % of sales 11.4% 9.8% 9.9% 11.7% 11.0%
Earnings per ordinary share in € 2.64 2.151) 1.761) 1.361) 0.931)
Earnings per preference share in € 2.65 2.161) 1.771) 1.371) 0.941)
Balance sheet          
Total assets 15,324 15,024 11,594 8,188 8,347
Non-current assets 11,033 10,918 8,063 5,433 5,603
Equity2) 6,059 5,728 5,130 3,347 3,214
Equity ratio2) 40% 38% 44% 41% 39%
Investments3) 1,318 4,314 2,247 421 430
Profitability          
EBIT margin 14.2% 13.4% 12.3% 11.6% 11.1%
Return on equity after taxes (ROE)4) 6) 12.0% 10.4% 11.4% 10.5% 7.5%
Return on operating assets (ROOA)4) 5) 11.4% 10.4% 11.7% 11.1% 9.8%
Return on invested capital (ROIC)4) 5) 8.4% 7.4% 8.0% 7.4% 6.3%
Dividend per ordinary share in €  0.667) 0.57  0.491)  0.451)  0.411)
Dividend per preference share in €  0.677) 0.58  0.501)  0.461)  0.421)
Employees (December 31) 114,181 104,872 91,971 68,494 66,264
 
1) Adjusted for share split in February 2007
2) Equity including minority interest
3) Investments in property, plant and equipment and intangible assets, acquisitions
4) 2005: balance sheet adjusted for acquisition of HELIOS Kliniken
5) 2006 pro forma Renal Care Group, excluding earnings from the divestiture of US dialysis clinics as well as their first quarter 2006 earnings
6) 2006 pro forma Renal Care Group, excluding first quarter 2006 earnings of divested US dialysis clinics
7) Proposal

You will find a 10-year overview on our website: www.fresenius-ag.com/InvestorRelations.

Key figures of the business segments

  FRESENIUS MEDICAL CARE
 		   FRESENIUS KABI
 
   
 
Dialysis products, Dialysis care,
Extracorporeal therapies

  
Infusion therapy, Clinical nutrition,
Transfusion technology
  2007
in mill. US$ 		2006
in mill. US$ 		Change
 		   2007
in million € 		2006
in million € 		Change
 
 
Sales
9,720		  
8,499		  
14%		    
2,030		  
1,893		  
7%
EBIT  1,580  1,318  20%    332  291  14%
Net income  717  537  34%    183  143  28%
Operating cash flow   1,200  908 32%    179  202  -11%
Capital expenditure/acquisitions   932  4,783  -81%    294  127  --
R & D expenses  67  51  31%    86  77  12%
Employees
(December 31) 		  64,662  59,996  8%    16,964  15,591  9%
  FRESENIUS HELIOS

   FRESENIUS VAMED
   
 
Hospital operation



  
Engineering and Services
for hospitals and other health
care facilities
  2007
in million €
 		2006
in million €
 Change   2007
in million €
 		2006
in million €
 Change
 
Sales
1,841		  
1,673		  
10%		    
408		  
392		  
4%
EBIT  155
  133  17%    26 23  13%
Net income  64 59  8%    23 20  15%
Operating cash flow   202 141 43%    72 34 112%
Capital expenditure/acquisitions 323  214  51%    10 5  100%
Order Intake  n/a n/a      395 337  17%
Employees
(December 31) 		  30,043 26,368 14%   1,767  1,768  0%

As from January 1, 2008, Fresenius ProServe was replaced by the two new business segments Fresenius Helios and Fresenius Vamed which previously formed Fresenius ProServe. Therefore, this new structure is already presented in this Annual Report. For Fresenius ProServe’s financial results please see the Management Report.